|
Volume
24 Number 20
31 October 2022
|
|
Home
>
Publications
>
Neuro-Oncology
Reviews >
Volume
24, Year 2022 >
Number 20, 31 October
|
|
|
|
|
|
Zhang J, Siller-Farfán JA.
Current
and future perspectives of chimeric antigen receptors against
glioblastoma.
Immunother Adv. 2022 Jun 1,
2022;2(1):ltac014→.
doi: 10.1093/immadv/ltac014→.
PMID: 36284838→.
Review. →
|
|
|
|
Khalil M, Shah Z, Saeed Baqai MW, Shamim MS.
Intraoperative
Seizures During Awake Craniotomy for Brain Tumours.
J
Pak Med Assoc. 2022 Sep;72(9):1878-1879→.
doi: 10.47391/JPMA.22-95? PMID: 36281000→.
Review. →
|
|
|
|
Li Y, Qin Q, Zhang Y, Cao Y.
Noninvasive
Determination of the IDH Status of Gliomas Using MRI and MRI-Based
Radiomics: Impact on Diagnosis and Prognosis.
Curr
Oncol. 2022 Sep 23, 2022;29(10):6893-6907→.
doi: 10.3390/curroncol29100542→.
PMID: 36290819→.
Review. →
|
|
|
|
Lim-Fat MJ, Macdonald M, Lapointe S, Climans SA, Cacciotti C,
Chahal M, Perreault S, Tsang DS, Gao A, Yip S, Keith J, Bennett J,
Ramaswamy V, Detsky J, Tabori U, Das S, Hawkins C.
Molecular
testing for adolescent and young adult central nervous system
tumors: A Canadian guideline.
Front Oncol. 2022
Sep 23, 2022;12:960509→.
doi: 10.3389/fonc.2022.960509→.
PMID: 36249063→.
Guidelines. →
|
|
|
|
Rossi J, Cavallieri F, Biagini G, Rizzi R, Russo M, Cozzi S,
Giaccherini L, Pisanello A, Valzania F.
Epileptogenesis
and Tumorigenesis in Glioblastoma: Which Relationship?
Medicina
(Kaunas). 2022 Sep 26, 2022;58(10):1349→.
doi: 10.3390/medicina58101349→.
PMID: 36295510→.
Review. →
|
|
|
|
Song S, Wu H, Wang F, Jiao J, Xu L, Wang H, Tong X, Yan H.
Global
research trends and hotspots on glioma stem cells.
Front
Oncol. 2022 Sep 29, 2022;12:926025→.
doi: 10.3389/fonc.2022.926025→.
PMID: 36248966→.
Bibliometric analysis. →
→
→
|
|
|
|
Zhou Y, Fang C, Xu H, Yuan L, Liu Y, Wang X, Zhang A, Shao A, Zhou
D.
Ferroptosis in glioma treatment:
Current situation, prospects and drug applications.
Front
Oncol. 2022 Sep 29, 2022;12:989896→.
doi: 10.3389/fonc.2022.989896→.
PMID: 36249003→.
Review. →
|
|
|
|
Buccarelli M, Castellani G, Ricci-Vitiani L.
Glioblastoma-Specific
Strategies of Vascularization: Implications in Anti-Angiogenic
Therapy Resistance.
J Pers Med. 2022 Oct 1,
2022;12(10):1625→.
doi: 10.3390/jpm12101625→.
PMID: 36294763→.
Review. →
|
|
|
|
Daneshimehr F, Barabadi Z, Abdolahi S, Soleimani M, Verdi J,
Ebrahimi-Barough S, Ai J.
Angiogenesis
and Its Targeting in Glioblastoma with Focus on Clinical
Approaches.
Cell J. 2022 Oct 1,
2022;24(10):555-568→.
doi: 10.22074/cellj.2022.8154→.
PMID: 36259473→.
Review. →
|
|
|
|
Guha A, Goda JS, Dasgupta A, Mahajan A, Halder S, Gawde J, Talole
S.
Classifying primary central
nervous system lymphoma from glioblastoma using deep learning and
radiomics based machine learning approach - a systematic review
and meta-analysis.
Front Oncol. 2022 Oct 3,
2022;12:884173→.
doi: 10.3389/fonc.2022.884173→.
PMID: 36263203→.
Review, Meta-analysis. →
|
|
|
|
Choi SI, Yin J.
Prospective
approaches to enhancing CAR T cell therapy for glioblastoma.
Front
Immunol. 2022 Oct 6, 2022;13:1008751→.
doi: 10.3389/fimmu.2022.1008751→.
PMID: 36275671→.
Review. →
|
|
|
|
Sánchez-Villalobos JM, Aledo-Serrano Á,
Villegas-Martínez I, Shaikh MF, Alcaraz M.
Epilepsy
treatment in neuro-oncology: A rationale for drug choice in common
clinical scenarios.
Front Pharmacol. 2022 Oct 6,
2022;13:991244→.
doi: 10.3389/fphar.2022.991244→.
PMID: 36278161→.
Review. →
|
|
|
|
Bartusik-Aebisher D, Żołyniak A, Barnaś E,
Machorowska-Pieniążek A, Oleś P, Kawczyk-Krupka A,
Aebisher D.
The Use of Photodynamic
Therapy in the Treatment of Brain Tumors-A Review of the
Literature.
Molecules. 2022 Oct 13,
2022;27(20):6847→.
doi: 10.3390/molecules27206847→.
PMID: 36296440→.
Review. →
|
|
|
|
van Bree NFHN, Wilhelm M.
The Tumor
Microenvironment of Medulloblastoma: An Intricate Multicellular
Network with Therapeutic Potential.
Cancers
(Basel). 2022 Oct 13, 2022;14(20):5009→.
doi: 10.3390/cancers14205009→.
PMID: 36291792→.
Review. →
|
|
|
|
Gaca-Tabaszewska M, Bogusiewicz J, Bojko B.
Metabolomic
and Lipidomic Profiling of Gliomas-A New Direction in Personalized
Therapies.
Cancers (Basel). 2022 Oct 14,
2022;14(20):5041→.
doi: 10.3390/cancers14205041→.
PMID: 36291824→.
Review. →
|
|
|
|
Gueble SE, Vasquez JC, Bindra RS.
The
Role of PARP Inhibitors in Patients with Primary Malignant Central
Nervous System Tumors.
Curr Treat Options Oncol.
2022 Oct 15, 2022;23(11):1566-1589→.
doi: 10.1007/s11864-022-01024-5→.
PMID: 36242713→.
Review˰ →
|
|
|
|
|
|
Knisely JPS, Fine HA.
Reirradiation
for Recurrent Glioblastoma: What We Know and What We Do Not.
J
Clin Oncol. 2022 Oct 19, 2022:JCO2201785→.
doi: 10.1200/JCO.22.01785→.
PMID: 36260825→.
Case report, Review. →
|
|
|
|
Mackenzie P, Vajdic C, Delaney G, Comans T, Morris L, Agar M,
Gabriel G, Barton M.
Radiotherapy
utilisation rates for patients with cancer as a function of age: A
systematic review.
J Geriatr Oncol. 2022 Oct 19,
2022:S1879-4068(22)00236-3→.
doi: 10.1016/j.jgo.2022.10.002→.
PMID: 36272958→.
Review˰ →
|
|
|
|
Marabitti V, Giansanti M, De Mitri F, Gatto F, Mastronuzzi A,
Nazio F.
Pathological implications
of metabolic reprogramming and its therapeutic potential in
medulloblastoma.
Front
Cell Dev Biol. 2022 Oct 19, 2022;10:1007641→.
doi: 10.3389/fcell.2022.1007641→.
PMID: 36340043→.
Review. →
|
|
|
|
Andersen BM, Reardon DA.
Immunotherapy
approaches for adult glioma: knowledge gained from recent clinical
trials.
Curr
Opin Neurol. 2022 Oct 21, 2022;35(6):803-813→.
doi: 10.1097/WCO.0000000000001118→.
PMID: 36367046→.
Review˰ →
|
|
|
*
|
Jovanovich N, Habib A, Head J, Anthony A, Edwards L, Zinn
PO.
Opinion: Bridging gaps and
doubts in glioblastoma cell-of-origin.
Front
Oncol. 2022 Oct 21, 2022;12:1002933→.
doi: 10.3389/fonc.2022.1002933→.
PMID: 36338762→.
Opinion. →
|
|
|
|
Mallick S, Benson R, Venkatesulu B, Melgandi W, Rath
GK.
Systematic Review and Individual
Patient Data Analysis of Uncommon Variants of Glioblastoma: An
Analysis of 196 Cases.
Neurol
India. 2022 Oct 21, 2022;70(5):2086-2092→.
doi: 10.4103/0028-3886.359222→.
PMID: 36352613→.
Review. →
|
|
|
|
Niemi JVL, Sokolov AV, Schiöth HB.
Neoantigen
Vaccines; Clinical Trials, Classes, Indications, Adjuvants and
Combinatorial Treatments.
Cancers (Basel). 2022
Oct 21, 2022;14(20):5163→.
doi: 10.3390/cancers14205163→.
PMID: 36291947→.
Review. →
|
|
|
|
Sachdeva P, Ghosh S, Ghosh S, Han S, Banerjee J, Bhaskar R, Sinha
JK.
Childhood Obesity: A Potential
Key Factor in the Development of Glioblastoma Multiforme.
Life
(Basel). 2022 Oct 21, 2022;12(10):1673→.
doi: 10.3390/life12101673→.
PMID: 36295107→.
Review. →
|
|
|
|
Yuile A, Satgunaseelan L, Wei J, Kastelan M, Back MF, Lee M, Wei
H, Buckland ME, Lee A, Wheeler HR.
Implications
of Concurrent IDH1
and IDH2
Mutations on Survival in Glioma-A
Case Report and Systematic Review.
Curr Issues Mol
Biol. 2022 Oct 21, 2022;44(10):5117-5125→.
doi: 10.3390/cimb44100348→.
PMID: 36286062→.
Case report, Review. →
|
|
|
|
Malhotra AK, Karthikeyan V, Zabih
V, Landry A, Bennett J, Bartels U, Nathan PC, Tabori U, Hawkins C,
Das S, Gupta S.
Adolescent
and young adult glioma: systematic review of demographic, disease,
and treatment influences on survival.
Neurooncol
Adv. 2022 Oct 22, 2022;4(1):vdac168→.
doi: 10.1093/noajnl/vdac168→.
PMID: 36479061→.
Review. →
|
|
|
|
Fioni F, Song JC, Ma ZL, Ghalwash AA.
Differentiation
of high grade glioma and solitary brain metastases by measuring
relative cerebral blood volume and fractional anisotropy: A
systematic review and Meta-Analysis of MRI diagnostic test
accuracy studies.
Br J Radiol. 2022 Oct 24,
2022:20220052→.
doi: 10.1259/bjr.20220052→.
PMID: 36278795→.
Review, Meta-analysis. →
|
|
|
|
Lehrer EJ, Kowalchuk RO, Ruiz-Garcia H, Merrell KW, Brown PD,
Palmer JD, Burri SH, Sheehan JP, Quninoes-Hinojosa A, Trifiletti
DM.
Preoperative stereotactic
radiosurgery in the management of brain metastases and
gliomas.
Front
Surg. 2022 Oct 24, 2022;9:972727→.
doi: 10.3389/fsurg.2022.972727→.
PMID: 36353610→.
Review. →
|
|
|
|
Ling SP, Ming LC, Dhaliwal JS, Gupta M, Ardianto C, Goh KW,
Hussain Z, Shafqat N.
Role of
Immunotherapy in the Treatment of Cancer: A Systematic
Review.
Cancers
(Basel). 2022 Oct 24, 2022;14(21):5205→.
doi: 10.3390/cancers14215205→.
PMID: 36358624→.
Review. →
|
|
|
|
Li H, Duan Y, Liu N, Dong J, Liang Y, Ju R.
Value
of DWI Combined with Magnetic Resonance Spectroscopy in the
Differential Diagnosis between Recurrent Glioma and Radiation
Injury: A Meta-Analysis.
Int
J Clin Pract. 2022 Oct 25, 2022;2022:1629570→.
doi: 10.1155/2022/1629570→.
PMID: 36380750→.
Meta-analysis. →
|
|
|
|
Bunse L, Bunse T, Krämer C, Chih YC, Platten M.
Clinical
and Translational Advances in Glioma
Immunotherapy.
Neurotherapeutics. 2022 Oct 27→.
doi: 10.1007/s13311-022-01313-9→.
PMID: 36303101→.
Review. →
|
|
|
|
Giambra M, Di Cristofori A, Valtorta S, Manfrellotti R, Bigiogera
V, Basso G, Moresco RM, Giussani C, Bentivegna A.
The
peritumoral brain zone in glioblastoma: where we are and where we
are going.
J Neurosci Res. 2022 Oct 27→.
doi: 10.1002/jnr.25134→.
PMID: 36300592→.
Review. →
|
|
|
|
Lim YJ.
Medical Treatment of
Pediatric Low-Grade Glioma.
Brain
Tumor Res Treat. 2022 Oct 27, 2022;10(4):221-225→.
doi: 10.14791/btrt.2022.0039→.
PMID: 36347636→.
Review. →
|
|
|
|
Schirrmacher V, van Gool S, Stuecker W.
Counteracting
Immunosuppression in the Tumor Microenvironment by Oncolytic
Newcastle Disease Virus and Cellular Immunotherapy.
Int
J Mol Sci. 2022 Oct 27, 2022;23(21):13050→.
doi: 10.3390/ijms232113050→.
PMID: 36361831→.
Review. →
|
|
|
|
Hosseinalizadeh H, Habibi Roudkenar M, Mohammadi Roushandeh A,
Kuwahara Y, Tomita K, Sato T.
Natural
killer cell immunotherapy in glioblastoma.
Discov
Oncol. 2022 Oct 28, 2022;13(1):113→.
doi: 10.1007/s12672-022-00567-1→.
PMID: 36305981→.
Review. →
|
|
|
|
Kutty S.
A
summary of common grading systems used in neurosurgical
practice.
Surg
Neurol Int. 2022 Oct 28, 2022;13:497→.
doi: 10.25259/SNI_731_2022→.
PMID: 36447867→.
Review. →
|
|
|
|
Li J, Feng L, Lu Y.
Glioblastoma
multiforme: Diagnosis, treatment, and invasion.
J
Biomed Res. 2022 Oct 28, 2022:1-11→.
doi: 10.7555/JBR.36.20220156→.
PMID: 36403983→.
Review. →
|
|
|
|
Luo Y, Tian G, Fang X, Bai S, Yuan G, Pan Y.
Ferroptosis
and Its Potential Role in Glioma: From Molecular Mechanisms to
Therapeutic Opportunities.
Antioxidants
(Basel). 2022 Oct 28, 2022;11(11):2123→.
doi: 10.3390/antiox11112123→.
PMID: 36358495→.
Review. →
|
|
|
|
Qi X, Jha SK, Jha NK, Dewanjee S, Dey A, Deka R, Pritam P,
Ramgopal K, Liu W, Hou K.
Antioxidants
in brain tumors: current therapeutic significance and future
prospects.
Mol Cancer. 2022 Oct 28,
2022;21(1):204→.
doi: 10.1186/s12943-022-01668-9→.
PMID: 36307808→.
Review. →
|
|
|
|
Catalano M, Serpe C, Limatola C.
Microglial
Extracellular Vesicles as Modulators of Brain Microenvironment in
Glioma.
Int
J Mol Sci. 2022 Oct 29, 2022;23(21):13165→.
doi: 10.3390/ijms232113165→.
PMID: 36361947→.
Review. →
|
|
|
|
Foo CY, Munir N, Kumaria A, Akhtar Q, Bullock CJ, Narayanan A, Fu
RZ.
Medical Device Advances in the
Treatment of Glioblastoma.
Cancers
(Basel). 2022 Oct 29, 2022;14(21):5341→.
doi: 10.3390/cancers14215341→.
PMID: 36358762→.
Review. →
|
|
|
|
Goldman M, Lucke-Wold B, Martinez-Sosa M, Katz J, Mehkri Y,
Valisno J, Quintin S.
Steroid
utility, immunotherapy, and brain tumor management: an update on
conflicting therapies.
Explor
Target Antitumor Ther. 2022 Oct 31, 2022;3(5):659-675→.
doi: 10.37349/etat.2022.00106→.
PMID: 36338521→.
Review. →
|
|
|
|
Szklener K, Mazurek M, Wieteska M, Wacławska M, Bilski M,
Mańdziuk S.
New Directions in
the Therapy of Glioblastoma.
Cancers
(Basel). 2022 Oct 31, 2022;14(21):5377→.
doi: 10.3390/cancers14215377→.
PMID: 36358795→.
Review. →
|
|
|
|
|
|
|
|
|
